SCG2 and myocardial infarction: Secretoneurin has been reported to increase VEGF-induced VEGFR2 activation and VEGF binding to human coronary artery endothelial cells (HCAECs) and induce the infarct border zone of coronary angiogenesis in a rat model of myocardial infarction [34].